Home > LSE Health and Social Care > Publications > The LSE Health Working Paper Series in Health Policy and Economics


The LSE Health Working Paper Series in Health Policy and Economics

The series enables staff and student researchers based at or affiliated with LSE Health, to make recent work and work in progress available to a wider audience. It is intended to reflect the range and diversity of theoretical and empirical work relating to health policy and economics carried out at LSE Health.

WP1| (PDF) Inequality in health care use among older people in the United Kingdom: an analysis of panel data by Sara Allin, Cristina Masseria and Elias Mossialos.

WP2| (PDF) A conceptual framework for community-based health insurance in low-income countries: social capital and economic development by Philipa Mladovsky and Elias Mossialos.

WP3| (PDF) Equity in the use of health services in Canada and its provinces by Sara Allin.

WP4| (PDF) Regulating private health insurance in the European Union: the implications of single market legislation and competition policy by Sarah Thomson and Elias Mossialos.

WP5| (PDF) Inferring the Value of Medical Research to the UK by Alistair McGuire and Maria Raikou.

WP6 (PDF) Medicines parallel trade in the European Union: a gravity specification by Joan Costa-Font and Panos Kanavos

WP8| (PDF) Gains in QALYs vs DALYs averted: the troubling implications of using residual life expectancy by Mara Airoldi

WP9| (PDF) Exploring the Pathways of Inequality in Health, Access and Financing in Decentralised Spain by Joan Costa-Fonta and Joan Gilb

WP10| (PDF) Conflict in the Doctor-Patient relation and Non-Adherence: A game theory approach by Charitini Stavropoulou and Dionysius Glycopantis

WP11| (PDF) Reflections on the Development of Health Inequalities Policy in the United Kingdom by Adam Oliver

WP12| (PDF) Decomposing cross-country differences in levels of obesity and overweight: does the social environment matter? by Joan Costa-Font, Daniele Fabbri and Joan Gil

WP13| (PDF) Parametric estimation of medical care costs under conditions of censoring by Maria Raikou and Alistair McGuire

WP14| (PDF) An explorative study of "preferred" health care decision rules by Adam Oliver

WP15| (PDF) Body Image, Peer Effects and Food Disorders: Evidence from a Sample of European Women by Joan Costa-Font and Mireia Jofre-Bonet

WP16|  (PDF) Does Hospital Competition Save Lives? Evidence From The Recent English NHS Choice Reforms by  Zack Cooper, Stephen Gibbons, Simon Jones and Alistair McGuire

WP17| (PDF) Technology diffusion and health care productivity: angioplasty in the UK by Alistair McGuire, Maria Raikou, Frank Windmeijer and Victoria Serra-Sastre

WP18| (PDF) Medicine prices, availability and affordability in Southern Brazil: a study of public and private facilities by Andréa Dâmaso Bertoldi, Ana Paula Helfer, Aline L Camargo, Noêmia UL Tavares, Panos Kanavos

WP19| (PDF) Do International Launch Strategies of Pharmaceutical Corporations Respond to Changes in the Regulatory Environment by Nebibe Varol, Joan Costa-Font and Alistair McGuire

WP20| (PDF) Persistence despite Action? Measuring the Patterns of Health Inequality in England (1997-2007) by Joan Costa-Font, Cristina Hernádez-Quevedo and Alistair McGuire

WP21| (PDF) Using a latent variable approach to measure the quality of English NHS hospitals by Irene Papanicolas and Alistair McGuire

WP22| (PDF) Using a Vector Autoregression Framework to measure the quality of English NHS hospitals by Irene Papanicolas and Alistair McGuire

WP23| (PDF) Demand and Pricing of Preventative Health Care by Sotiris Vandoros and Katherine Grace Carman

WP24| (PDF) Pathways towards chronic-care focused healthcare systems: evidence from Spain by Manuel García-Goñi, Cristina Hernández-Quevedo, Roberto Nuño-Solinís, Francesco Paolucci

WP25| (PDF) Publication Selection in Health Policy Research: the Winner's Curse Hypothesis by Joan Costa-Font, Alistair McGuire and Tom Stanley

WP26| (PDF) Are Health Care 'Choice - and - Competition' Reforms really Efficiency Driven? by Joan Costa-Font and Valentina Zigante

WP27| (PDF) Does culture matter at all in explaining why people still use traditional medicines? by Azusa Sato and Joan Costa-i-Font

WP28| (PDF) The hedonic placebo effect of traditional medicines by Azusa Sato and Joan Costa-i-Font

WP29| (PDF) Do Income Gradients in Unhealthy Behaviours Explain Patterns of Health Inequalities? by Joan Costa-i-Font, Cristina Hernández-Quevedo and Dolores Jiménez-Rubio

WP30| (PDF) Intergenerational and Socioeconomic Gradients of Child Obesity by Joan Costa-Font and Joan Gil

WP31| (PDF) Globesity: Is Globalization a Pathway to Obesity? by Joan Costa-Font, Núria Mas and Patricia Navarro

WP32| (PDF) Inequalities in Self-Reported Health: A Meta-Regression Analysis by Joan Costa-Font and Cristina Hernández-Quevedo 

WP33| (PDF) Multiple Criteria Decision Analysis for Value Based Assessment of New Medical Technologies: A Conceptual Framework by Panos Kanavos and Aris Angelis

WP34 (PDF) Using MCDA to assess value of new medical technologies by Aris Angelis and Panos Kanavos 

WP35| (PDF) Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? by Divya Srivastava and Alistair McGuire

WP36| (PDF) Policy Dilemmas in Financing Long-term Care in Europe by Joan Costa-Font, Christophe Courbage and Peter Zweifel

WP37| (PDF) Long Term Care Coverage in Europe: A Case for 'Implicit Insurance Partnerships' by Joan Costa-Font and Valentina Zigante

WP38| (PDF) Assessing Long-Term Care Partnerships: An Old Concept to Redefine? by Savannah Bergquist, Joan Costa-Font and Katherine Swartz

WP39| (PDF) Treating epilepsy during pregnancy: a systematic literature review of the impact of drug treatment on mother and foetus by Federico Grimaccia and Panos Kanavos

WP40| (PDF) Treating rheumatoid arthritis during pregnancy: A systematic literature review of the impact of drug treatment on mother and foetus by Victoria Tzouma, Mari Grepstad and Panos Kanaovs

WP41| (PDF) Treating schizophrenia during pregnancy: A systematic literature review on the impact of drug treatment on mother and foetus by Mari Grepstad, Victoria Tzouma, Federico Grimaccia and Panos Kanaovs

WP42| (PDF) An analysis of HTA decisions for orphan drugs in Canada and Australia by Caroline Solon and Panos Kanavos

WP43| (PDF) Health Technology Assessment of Cancer Drugs in France and Germany - Commonalities and Differences in the Value Assessment of Medical Technologies by Anna Szerb and Panos Kanavos

WP44| (PDF) Comparisons of Health Technology Assessment Appraisal Outcomes and Methodologies in Oncology Indications across Four Countries by Nick Petersdorf and Panos Kanavos

WP45| (PDF) A Comparative Analysis of the Regulatory Requirements of Orphan Medicinal Products in the United States and European Union by Emilie Taymor and Panos Kanavos

For any other information about the series, please contact: Anthony Kelly (a.p.kelly1@lse.ac.uk|) Managing Editor.